AstraZeneca
VerifiedA global, science-led biopharmaceutical company that focuses on the discovery, development and commercialisation of prescription medicines.
Launch date
Employees
Market cap
-
Net debt
-
Enterprise valuation
$266.7b (Public information from May 2024)
Share price
$76.9 AZN
Company register number 03674842
Cambridge England (HQ)
Deals in current and previous year:
Corporate Venture Fund: AstraZeneca Pharmaceutical
No columns specified